In the dynamic landscape of healthcare and life sciences, the integration of cutting-edge technologies has become paramount. Among these innovations, Artificial Intelligence (AI) stands out as a transformative force, reshaping everything from drug discovery to patient care. In this white paper, Tanuj Mehra, Jordan Schell, Erion Lipo and Kevin Yin shed light on the pivotal role of AI, particularly Generative AI.
At the heart of this transformation lies Generative AI, a technology that simulates human intelligence in machines, encompassing machine learning, natural language processing, and computer vision. This versatile tool has found widespread recognition, catalyzing mainstream adoption and driving innovation across various sectors.
The white paper delves into the diverse applications of AI in life sciences, ranging from pharmaceutical research and development to patient engagement and care. From accelerating clinical trials through patient recruitment to enhancing diagnostic accuracy through image analysis, AI is revolutionizing every facet of healthcare delivery.
However, despite the promise of AI, challenges abound. Roadblocks such as leadership buy-in, understanding AI capabilities, and navigating regulatory concerns pose significant hurdles. To address these challenges, the white paper introduces EVERSANA’s Generative AI Implementation Pathway, a structured approach designed to guide organizations through the complexities of AI integration.
The pathway consists of three phases: READY, SET, and GO. In the READY phase, organizations gain an understanding of Generative AI and conduct a landscape assessment. The SET phase involves ideating use cases, developing business cases, and planning pilots. Finally, in the GO phase, organizations execute pilots, define operating models, allocate resources, and continuously monitor and improve AI integration.
Complete the form below to download the full white paper to learn more about the immense potential of Generative AI in healthcare and life sciences.
Author
Tanuj Mehra brings more than a decade of experience working at the intersection of commercial and R&D with both large pharmaceutical and smaller biopharma clients. He has led numerous global engagements with leading Fortune…
Erion is a Consultant at EVERSANA MANAGEMENT CONSULTING, with a background in microbiology research, genetics, and molecular biology. Erion has leveraged his foundational academic knowledge to perform market research, develop pipeline prioritization strategies, and…
Kevin Yin is a Consultant with EVERSANA MANAGEMENT CONSULTING with a combined science and business background and over 5 years of experience working in the life sciences industry. Before joining EVERSANA MANAGEMENT CONSULTING, Kevin…
Jordan Schell is an Associate Partner at EVERSANA MANAGEMENT CONSULTING. With 15 years of life sciences experience, he has worked across large, mid-size, and start-up pharmaceutical and biotech companies to define, execute, and deliver…